Breast MRI texture analysis for prediction of BRCA-associated genetic risk.
Georgia VasileiouMaria J CostaChristopher LongIris R WetzlerJuliane HoyerCornelia KrausBernt PoppJulius EmonsMarius WunderleEvelyn WenkelMichael UderMatthias W BeckmannSebastian M JudPeter A FaschingAlexander CavallaroAndré ReisMatthias HammonPublished in: BMC medical imaging (2020)
The L-PCR model uncovered evidence for the utility of MRI texture features in distinguishing between BRCA1/2 positive and negative high-risk breast cancer individuals, which may suggest value to diagnostic routine. Integration of computer-extracted texture analysis from MRI modalities in prediction models and inclusion criteria might play a role in reducing false positives or missed cases especially when established risk variables such as family history are missing.